“The loneliness, sadness, and melancholic hum of my life all validated by 10,000 antidepressants. I…
Author: Emma Yasinski
I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.
In the last week of September 2021, a group of more than 90 doctors and researchers published a call to action, cautioning against the liberal use of Tylenol (acetaminophen) during pregnancy. The studies suggested that exposure to the drug could increase the risk of a baby having neurodevelopmental, reproductive and urogenital disorders. The authors added, however, that Tylenol has long been considered one of the few safer options to treat pain in pregnancy, since Advil (ibuprofen) and opioids are considered riskier. They pointed out that, in some cases, a woman’s condition (fever and pain, for example) could be worse for…
There are at least six octopus trinkets on the desk separating me from Duncan Ross, PhD, CEO of Kimera Labs, a company that produces exosomes, stem cell derivatives that contain molecular information believed to help cells heal.
When Matthew Feshbach, then an investor, first heard about a California company developing treatments for a variety of diseases using stem cells derived from a patient’s own fat cells (autologous adipose-derived cells), he thought, That’s the biggest idea I’ve ever heard.
You can find regenerative medicine in many settings, ranging from academic medical centers, to facilities dedicated to providing only stem cell treatments to an individual doctor or even chiropractor’s office. With such variability, it’s important to ask questions to make sure the treatment you’re considering will be as safe as possible.
“Time’s up,” said the Food and Drug Administration (FDA). A three-and-a-half-year grace period during which companies manufacturing and providing regenerative medicine procedures were instructed to get their operations in line with new, clarified rules announced in 2017, ended May 31.
MedShadow Foundation is an independent nonprofit health & wellness journalism organization focused on helping to protect lives from the side effects of medication and lower risk with alternative health options.
We help protect your life and the lives of your family by making sure you have the information you need to make informed decisions about the risks, benefits and alternatives to medicines.
Even though MedShadow is nonprofit, we refuse to accept support from pharmaceutical companies or medical device manufacturers. You can be sure that our information is free from the influence of pharmaceutical companies.
Symptoms & Concerns
MedShadow Foundation does not provide medical advice, diagnosis or treatment.
This site complies with the HONcode standard for trustworthy health information.
MedShadow Foundation is a registered 501(c)(3) non-profit organization. MedShadow does not accept advertising or contributions from pharmaceutical companies, medical device manufacturers or political action organizations.
Copyright © 2022, MedShadow Foundation. all rights reserved. Designed by Dante Steward